Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1699024 | 0.96 | ALOX5 (0.32) | ALOX5 | |
| SCHEMBL2439508 | 0.87 | ALOX5 (0.30) | ALOX5 | |
| SCHEMBL2442060 | 0.87 | CYP2C19 (0.34) | ALOX5 | |
| SCHEMBL2436360 | 0.85 | CYP2C19 (0.38) | — | |
| SCHEMBL23803960 | 0.80 | CYP2C19 (0.35) | ALOX5 | |
| SCHEMBL3363296 | 0.79 | KMT2A (0.50) | — | |
| SCHEMBL2437590 | 0.79 | KMT2A (0.50) | — | |
| SCHEMBL2442717 | 0.78 | ALOX5 (0.31) | ALOX5 | |
| SCHEMBL10176446 | 0.77 | — | — | |
| SCHEMBL2441216 | 0.77 | ALDH1A1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180258371-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-09-13 | — | — | US | disclosed |
| US-9994793-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2018-06-12 | — | — | US | disclosed |
| EP-3121255-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-03-28 | — | — | EP | disclosed |
| EP-3287511-A1 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2018-02-28 | — | — | EP | disclosed |
| EP-3121256-A1 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2017-01-25 | — | — | EP | disclosed |
| EP-3121255-A1 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2017-01-25 | — | — | EP | disclosed |
| US-20160326458-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-11-10 | — | — | US | disclosed |
| US-20150141310-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2015-05-21 | — | — | US | disclosed |
| US-8987187-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2015-03-24 | — | — | US | disclosed |
| US-20110308556-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141310-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | ALOX5 220/4885 |
| US-20110308556-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | ALOX5 220/4885 |
| US-20180258371-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | ALOX5 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.